Fangmei Luo

机构：Shanghai University of Traditional Chinese Medicine, Yueyang Second People's Hospital, Yueyang Hospital

发表论文 10 篇 · 总被引 155 次 · h-index 7

代表论文

• Magnolol Attenuates Right Ventricular Hypertrophy and Fibrosis in Hypoxia-Induced Pulmonary Arterial Hypertensive Rats Through Inhibition of the JAK2/STAT3 Signaling Pathway (2021 · Frontiers in Pharmacology · 被引 35)
• Cerebellin-2 promotes endothelial-mesenchymal transition in hypoxic pulmonary hypertension rats by activating NF-κB/HIF-1α/Twist1 pathway (2023 · Life Sciences · 被引 27)
• Down-regulation of the mitochondrial fusion protein Opa1/Mfn2 promotes cardiomyocyte hypertrophy in Su5416/hypoxia-induced pulmonary hypertension rats (2023 · Archives of Biochemistry and Biophysics · 被引 23)
• Coordination between NADPH oxidase and vascular peroxidase 1 promotes dysfunctions of endothelial progenitor cells in hypoxia-induced pulmonary hypertensive rats (2019 · European Journal of Pharmacology · 被引 18)
• Metabolic Enzyme System and Transport Pathways in Chronic Kidney Diseases (2018 · Current Drug Metabolism · 被引 17)
• Evaluating the therapeutic role of selected active compounds in Plumula Nelumbinis on pulmonary hypertension via network pharmacology and experimental analysis (2022 · Frontiers in Pharmacology · 被引 15)